Raymond Tabibiazar

Director at Pacegenix.

Raised on Pacegenix filings

$22.5M

of $22.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Mar 26, 2026

Company

Biotech · Cambridge, MA

Prodrugs for atrial fibrillation and fast heart rates

Prodrugs for atrial fibrillation and fast heart rates

Investors: 15
Founded: 2024

Investors: 15
Sector: Biotech
Founded: 2024
HQ: Cambridge, MA

Pacegenix filings

Pacegenix Form D filings
Filed	Security	Sold of offered	Filing
Mar 26, 2026	Equity	$22.5M/ $22.5M	Form D

EquityFiled Mar 26, 2026Form D
$22.5M/ $22.5M

Works with

Also named on Pacegenix filings

Jay Glenn WohlgemuthChief Executive Officer, Form D signerForm D signer Frank Grazzini, IIExecutive Officer Fredric Neville EshelmanDirector